Because it acts on a different pathway than GLP-1 drugs, the National Institute of Diabetes and Digestive and Kidney Diseases describes how prescription medications treat overweight and obesity by changing appetite signaling rather than relying on willpower
Drmanac R, Sparks AB, Callow MJ et al : Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays
Based on data from Phase 2 clinical trials published in the New England Journal of Medicine (2023), retatrutide is administered as a once-weekly subcutaneous injection , typically into the abdomen, thigh, or upper arm
Brain Behav Immun 64:367383
Instead, it reveals two distinct approaches to the same problem, each with advantages in specific contexts
This interest stems primarily from the medication's profound effects on weight loss and metabolic health, both of which are connected to reproductive function